Reports of Sexual Disorders Related to Serotonin Reuptake Inhibitors in the French Pharmacovigilance Database: An Example of Underreporting

被引：0
|
作者：
Thierry Trenque
Géric Maura
Emmanuelle Herlem
Catherine Vallet
Elodie Sole
Pascal Auriche
Moustapha Drame
机构：
[1] Reims University Teaching Hospitals,Regional Centre for Pharmacovigilance and Pharmacoepidemiology
[2] University of Reims Champagne-Ardenne,Faculty of Medicine
[3] ANSM,Pharmacovigilance Department
[4] Reims University Hospitals,Department of Research and Innovation
来源：
Drug Safety | 2013年 / 36卷
关键词：
Sexual Dysfunction; Fluvoxamine; Duloxetine; Escitalopram; Premature Ejaculation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：515 / 519
页数：4
相关论文
共 50 条
  • [1] Reports of Sexual Disorders Related to Serotonin Reuptake Inhibitors in the French Pharmacovigilance Database: An Example of Underreporting
    Trenque, Thierry
    Maura, Geric
    Herlem, Emmanuelle
    Vallet, Catherine
    Sole, Elodie
    Auriche, Pascal
    Drame, Moustapha
    DRUG SAFETY, 2013, 36 (07) : 515 - 519
  • [2] Suicidality and Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenalin Reuptake Inhibitors: Analysis of the French Pharmacovigilance Database
    Tan, S.
    Le Beller, C.
    Coudore, F.
    Auriche, P.
    Le Louet, A. Lillo
    DRUG SAFETY, 2011, 34 (10) : 1009 - 1010
  • [3] Selective Serotonin Reuptake Inhibitors (SSRIs) and Hyperprolactinemia: Analysis of the French Pharmacovigilance Database
    Oger, F.
    Buire, A. C.
    Trenque, T.
    DRUG SAFETY, 2008, 31 (10) : 932 - 932
  • [4] Selective serotonin Reuptake Inhibitors (SSRIs) and Hyperprolactinemia: Analysis of the French Pharmacovigilance Database
    F. Oger
    A. C. Buire
    T. Trenque
    Drug Safety, 2008, 31 : 885 - 885
  • [5] Serotonin Reuptake Inhibitors and HyperprolactinaemiaA Case/Non-Case Study in the French Pharmacovigilance Database
    Thierry Trenque
    Emmanuelle Herlem
    Pascal Auriche
    Moustapha Dramé
    Drug Safety, 2011, 34 : 1161 - 1166
  • [6] Serotonin Reuptake Inhibitors and Hyperprolactinaemia A Case/Non-Case Study in the French Pharmacovigilance Database
    Trenque, Thierry
    Herlem, Emmanuelle
    Auriche, Pascal
    Drame, Moustapha
    DRUG SAFETY, 2011, 34 (12) : 1161 - 1166
  • [7] Selective serotonin reuptake inhibitors (ssriss) and sexual disorders
    Vallet, C.
    Maura, G.
    Herlem, E.
    Trenque, T.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 21 - 21
  • [8] Selective Serotonin Reuptake Inhibitors (SSRIs) and Sexual Disorders
    Herlem, E.
    Germain, M. L.
    Trenque, T.
    DRUG SAFETY, 2010, 33 (10) : 913 - 914
  • [9] Isolated cough induced by selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors: what do the summary of product characteristics and the french pharmacovigilance database say?
    Alleman-Brimault, I.
    Paret, N.
    Dautriche, A.
    Becker, M.
    Jean-Pastor, M. J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 46 - 47
  • [10] Selective Serotonin Reuptake Inhibitors and Venous Thromboembolism: a Pharmacovigilance Analysis of the Eudravigilance Database
    Lopes, Andreia
    Prada, Luisa
    Avo-Baiao, Rita
    Fernandes, Joao
    Silva, Marcia
    DRUG SAFETY, 2024, 47 (12) : 1409 - 1409
12345